Lucid Diagnostics (LUCD) Revenue Growth (3y) (2024 - 2026)
Lucid Diagnostics (LUCD) Revenue Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 10.52% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 2.92% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 17.14% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 0.73% |
| 10 | Lucid Diagnostics | 126.89 Mn | 99.01 Mn | -325,000.00 | 42.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.85% |
| Dec 31, 2025 | 137.37% |
| Sep 30, 2025 | 151.64% |
| Mar 31, 2025 | 63.63% |
| Dec 31, 2024 | 58.61% |
| Sep 30, 2024 | 80.29% |